跳至主要内容
临床试验/NCT01694810
NCT01694810已完成1 期

A Phase 1 Multiple Dose, Single-Center, Observer-Blind Parallel Group Study Evaluating Safety and Cutaneous Tolerability of NVN1000 Topical Gel in Healthy Volunteers

Novan, Inc.1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2012年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
Novan, Inc.
入组人数
60
试验地点
1
主要终点
Cutaneous tolerability Evaluation

研究概览

简要总结

The study will assess safety and tolerability of different doses of topical gel containing a new chemical entity, NVN1000, and the vehicle (gel without drug) applied to the face of healthy volunteers with high counts of Propionibacterium acnes. The test product will be applied once daily for 4 weeks. Exploratory measures include whether the topical product decreases the amount of a bacteria associated with acne (P. acnes).

详细描述

This is a single center, observer blinded, randomized, multiple dose study with 3 doses of NVN1000 and vehicle applied once daily for 4 weeks. There are 4 arms to the study (3 active and 1 vehicle).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy male and female volunteers
  • Age 18 or older
  • High degree of fluorescence of facial skin under Wood's lamp

排除标准

  • Acute or chronic skin disorders
  • Use of topical or systemic antibiotics within 4 weeks of study
  • Concomitant use of nitroglycerin or other nitric oxide donor drugs
  • Females who are pregnant, planning pregnancy or breast feeding

研究组 & 干预措施

8% NVN1000 Topical Gel

Experimental

8% NVN1000 8% Topical Gel applied once daily for 4 weeks

干预措施: 8% NVN1000 Topical Gel (Drug)

2% NVN1000 Topical Gel

Experimental

2% NVN1000 Topical Gel once daily for 4 weeks

干预措施: 2% NVN1000 Topical Gel (Drug)

4% NVN1000 Topical Gel

Experimental

4% NVN1000 4% Topical Gel once daily for 4 weeks

干预措施: 4% NVN1000 Topical Gel (Drug)

Vehicle Topical Gel

Placebo Comparator

Vehicle Topical Gel once daily for 4 weeks

干预措施: Vehicle Topical Gel (Drug)

结局指标

主要结局

Cutaneous tolerability Evaluation

时间窗: 4 weeks

Cutaneous tolerability evaluations to include erythema, scaling, dryness, puritus and burning/stinging using a 4-category scale with scores ranging from 0-3 (0=none, 1=mild, 2=moderate, 3 - severe).

次要结局

  • Safety Assessment(4 weeks)

研究者

发起方
Novan, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验